SciSparc (SPRC) Cash & Equivalents (2016 - 2026)
SciSparc's Cash & Equivalents came in at $4.44 million for Q2 2026, up 187.1% from $1.55 million a year earlier.
Powered by 
Analysis
SciSparc (SPRC) Cash & Equivalents (2016 - 2026) Analysis & Trends
At the end of FY2025, SciSparc's Cash & Equivalents was $4.59 million, up 198.1% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of 18.7% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $1.54 million in FY2024 (-25.8%), $2.08 million in FY2023 (-41.9%), $3.57 million in FY2022 (-48.0%) and $6.88 million in FY2021 (+253.3%).
- The five-year range for quarterly Cash & Equivalents is $252,000 (Q2 2024) to $12.95 million (Q2 2022).
- Year-over-year, Cash & Equivalents increased in three of the last four quarters, with growth averaging 218.1%.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q2 2025 (growth of 513.1%), and the weakest in Q2 2024 (a decline of 87.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 976.00 Mn |
| 10 | SciSparc | 135,361.65 | -14.30 Mn | - | 4.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.44 Mn |
| Dec 31, 2025 | 4.59 Mn |
| Jun 30, 2025 | 1.55 Mn |
| Dec 31, 2024 | 1.54 Mn |
| Jun 30, 2024 | 252,000.00 |
| Dec 31, 2023 | 2.08 Mn |
| Jun 30, 2023 | 2.08 Mn |
| Dec 31, 2022 | 3.57 Mn |
| Jun 30, 2022 | 12.95 Mn |
| Dec 31, 2021 | 6.88 Mn |
| Jun 30, 2021 | 7.59 Mn |
| Dec 31, 2020 | 1.95 Mn |
| Jun 30, 2020 | 144,000.00 |
| Dec 31, 2019 | 870,000.00 |
| Jun 30, 2019 | 1.59 Mn |
| Mar 31, 2019 | 2.58 Mn |
| Dec 31, 2018 | 1.49 Mn |
| Sep 30, 2018 | 2.03 Mn |
| Jun 30, 2018 | 5.10 Mn |
| Mar 31, 2018 | 7.51 Mn |
API Access
SciSparc Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SPRC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "SPRC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SPRC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();